Entero Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -35 | -12 | -7 | |
EBITDA | -1,891 | -3,390 | -9,213 | -4,086 |
EBIT | -1,892 | -3,426 | -9,226 | -4,093 |
Net Income | -2,580 | -8,807 | 5,567 | -4,100 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,848 | -3,450 | -3,746 | -3,939 |
Cash | 366 | 662 | 3,431 | 3,711 |
Basic Shares | 4,552 | 2,294 | 1,761 | 1,560 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -29 | -106 | -537 | -571 |
EBITDA | -15,743 | -14,507 | -57,989 | -26,259 |
EBIT | -15,772 | -14,536 | -58,531 | -26,825 |
Net Income | -15,794 | -14,629 | -58,537 | -32,671 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,877 | -22,344 | -42,607 | -11,225 |
Cash | 3,711 | 1,362 | 8,248 | 6,062 |
Basic Shares | 336 | 35 | 2 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.58 |
2024-06-30 | -$3.85 |
2024-03-31 | $0.38 |
2023-12-31 | -$5.35 |
